The Special Situation Report #97: 1/28 Roundup
The Special Situation Report #97: 1/28 Roundup
Summary of the Week in Special Situations
Table of Contents:
Update on Developing M&A
Update on Shareholder Activism
Update on Other Special Situations
Announced M&A
Update on Developing M&A
Strategic Alternatives & Ongoing Situations
Choice Hotels (CHH) escalated its attempt to acquire Wyndham Hotels & Resorts (WH) by nominating eight individuals to replace Wyndham's current board (Filing)
Macy's (M) rejected a $21.00 per share unsolicited proposal from Arkhouse Management and Brigade Capital Management (Press Release)
Rumors
Dyne Therapeutics (DYN) reportedly speaking with advisers about a sale or partnership after receiving takeover interest (Bloomberg)
MorphoSys AG (MOR) reportedly working with an investment bank after garnering takeover interest (Seeking Alpha)
Paramount Global (PARA) M&A chatter continues as David Ellison reportedly made an offer to buy its parent National Amusements (Bloomberg)
Tellurian (TELL) reportedly hired Lazard to explore a sale of the LNG company (Bloomberg)
Update on Shareholder Activism
Xperi (XPER) activist investor Rubric Capital Management reportedly wants the company to reduce expenses and evaluate alternatives for its artificial intelligence unit (Bloomberg); plans to nominate directors for the company's board (Filing)
Update on Other Special Situations
Sanofi (SNY) agreed to acquire certain assets from biopharmaceutical company Inhibrx (INBX) in a deal valued at up to $2.2bn (Press Release)
Walgreens Boots (WBA) reportedly evaluating options including the sale of its Shields Health Solutions specialty pharmacy business (Reuters)
Announced M&A
Target / Acquirer – Approximate Transaction Enterprise Value
Energy & Natural Resources
NuStar Energy (NS) / Sunoco (SUN) – $7.3bn (Press Release, Presentation)
If you enjoyed reading this Report, please do me the huge favor of simply pressing the “Like” button.
The content herein is informational and should not be relied upon as fact. Do your own diligence before making any investment decisions.